OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Givosiran: A Review in Acute Hepatic Porphyria
Yahiya Y. Syed
Drugs (2021) Vol. 81, Iss. 7, pp. 841-848
Closed Access | Times Cited: 66

Showing 26-50 of 66 citing articles:

TGFBI R124H mutant allele silencing in granular corneal dystrophy type 2 using topical siRNA delivery
Andrew McLain, Amanda Kowalczyk, Paulina Rachwalska, et al.
Journal of Controlled Release (2025), pp. 113681-113681
Closed Access

Neurological Manifestations of Acute Porphyrias
Kyle Wylie, Fernando D. Testai
Current Neurology and Neuroscience Reports (2022) Vol. 22, Iss. 7, pp. 355-362
Closed Access | Times Cited: 17

Recent Advances in RNA Therapy and Its Carriers to Treat the Single-Gene Neurological Disorders
Ming‐Jen Lee, Inyoul Lee, Kai Wang
Biomedicines (2022) Vol. 10, Iss. 1, pp. 158-158
Open Access | Times Cited: 16

Clinical pharmacology of siRNA therapeutics: current status and future prospects
Ahmed Abosalha, Jacqueline L. Boyajian, Waqar Ahmad, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 11, pp. 1327-1341
Closed Access | Times Cited: 16

Non-coding RNA-directed therapeutics in lung cancer: Delivery technologies and clinical applications
Ahmed A. H. Abdellatif, Giulia Scagnetti, Mahmoud A. Younis, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 229, pp. 113466-113466
Open Access | Times Cited: 9

Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria
Karol M. Córdoba, Irantzu Serrano-Mendioroz, Daniel Jericó, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 627
Open Access | Times Cited: 14

A tiny loop in the Argonaute PIWI domain tunes small RNA seed strength
Yao Xiao, TingYu M Liu, Ian J. MacRae
EMBO Reports (2023) Vol. 24, Iss. 6
Open Access | Times Cited: 8

Acute Intermittent Porphyria: A Review and Rehabilitation Perspective
Adriana Valbuena Valecillos, Puja Yatham, Matison Alderman, et al.
Cureus (2023)
Open Access | Times Cited: 8

Biodistribution and delivery of oligonucleotide therapeutics to the central nervous system: Advances, challenges, and future perspectives
Akihiko Goto, S. Yamamoto, Shinji Iwasaki
Biopharmaceutics & Drug Disposition (2022) Vol. 44, Iss. 1, pp. 26-47
Open Access | Times Cited: 14

siRNA-mediated gene silencing for non-alcoholic fatty liver disease: A comprehensive review of molecular targets
Ali Mahmoudi, Mehdi Rostami, Mohammad Mahdi Hajihasani, et al.
European Polymer Journal (2024) Vol. 208, pp. 112866-112866
Closed Access | Times Cited: 2

Revealing the dynamic whole transcriptome landscape of Clonorchis sinensis: Insights into the regulatory roles of noncoding RNAs and microtubule-related genes in development
Yang‐Yuan Qiu, Cunzhou Wang, Jing Wang, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 7, pp. e0012311-e0012311
Open Access | Times Cited: 2

Development of RNA interference-based therapy for rare genetic diseases
Milya Urfa Ahmad, Syarifah Dewi
Acta Biochimica Indonesiana (2024) Vol. 7, Iss. 1, pp. 171-171
Open Access | Times Cited: 2

Emerging RNAi Therapies to Treat Hypertension
Pawan Daga, Gurnoor Singh, Tushar Menon, et al.
Molecular Diagnosis & Therapy (2024)
Closed Access | Times Cited: 2

A case report of acute intermittent porphyria leading to severe disability
Jie Lin, Jinzhi Liu, Aihua Wang, et al.
Frontiers in Neurology (2024) Vol. 14
Open Access | Times Cited: 1

Recent applications of RNA therapeutic in clinics
Huyen Trang Ha Thi, Van Thai Than
Progress in molecular biology and translational science (2024), pp. 115-150
Closed Access | Times Cited: 1

Study on the molecular interactions between givosiran and theophylline by surface-enhanced Raman spectroscopy, biolayer interferometry, and visible/fluorescence spectroscopy
Lijuan He, Zhilan Lian, Jiadong Feng, et al.
Microchemical Journal (2024) Vol. 203, pp. 110846-110846
Closed Access | Times Cited: 1

Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
Su-Eon Jin, Jong‐Hyuk Sung
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7612-7612
Open Access | Times Cited: 1

German Real-World Experience of Patients with Diverse Features of Acute Intermittent Porphyria Treated with Givosiran
Ilja Kubisch, Nils Wohmann, Thaddäus Till Wissniowski, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6779-6779
Open Access | Times Cited: 1

Hepatocyte targeting via the asialoglycoprotein receptor
Fabricio Ramírez-Cortés, Petra Ménová
RSC Medicinal Chemistry (2024)
Open Access | Times Cited: 1

Epigenetic inhibitors and their role in cancer therapy
Nouha Abdelaziz, Lubna Therachiyil, Hana Q. Sadida, et al.
International review of cell and molecular biology (2023), pp. 211-251
Closed Access | Times Cited: 3

Gene Therapy Products Reached to Market by 2021
Sümbül Yıldırım, Fatih Kocabaş
Gene Editing (2021) Vol. 2, Iss. 2, pp. 1-21
Open Access | Times Cited: 5

An introduction to RNA therapeutics and their potentials
Nhat Le Bui, Dinh‐Toi Chu
Progress in molecular biology and translational science (2024), pp. 1-12
Closed Access

RNA therapeutics for metabolic disorders
Thuy-Duong Vu, Sheng‐Che Lin, Chia-Ching Wu, et al.
Progress in molecular biology and translational science (2024), pp. 181-196
Closed Access

Small interfering RNA: potential in real-world clinical practice
A. S. Motrinchuk, А. Р. Касимова
Real-World Data & Evidence (2024) Vol. 4, Iss. 1, pp. 3-13
Open Access

Scroll to top